![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma
Danijela Drakulić, Marija Schwirtlich, Isidora Petrović, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2530-2530
Open Access | Times Cited: 15
Danijela Drakulić, Marija Schwirtlich, Isidora Petrović, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2530-2530
Open Access | Times Cited: 15
Showing 15 citing articles:
The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma
Can Bora Yildiz, Jian Du, K. Naga Mohan, et al.
Epigenomics (2025), pp. 1-16
Closed Access
Can Bora Yildiz, Jian Du, K. Naga Mohan, et al.
Epigenomics (2025), pp. 1-16
Closed Access
YAP/TAZ-associated cell signaling – at the crossroads of cancer and neurodevelopmental disorders
Aderonke O. Ajongbolo, Sigrid A. Langhans
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Aderonke O. Ajongbolo, Sigrid A. Langhans
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Emerging Therapies for Glioblastoma
Stella Rios, Stephanie Oyervides, David Uribe, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1485-1485
Open Access | Times Cited: 5
Stella Rios, Stephanie Oyervides, David Uribe, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1485-1485
Open Access | Times Cited: 5
Regulation of cancer stem cells and immunotherapy of glioblastoma (Review)
Aleksandra A. Kosianova, Oleg Pak, Igor Bryukhovetskiy
Biomedical Reports (2023) Vol. 20, Iss. 2
Open Access | Times Cited: 7
Aleksandra A. Kosianova, Oleg Pak, Igor Bryukhovetskiy
Biomedical Reports (2023) Vol. 20, Iss. 2
Open Access | Times Cited: 7
Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy
S. M. Murshid Hasan, Zimam Mahmud, Mahmud Hossain, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
S. M. Murshid Hasan, Zimam Mahmud, Mahmud Hossain, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma IDH Wildtype
Elham Kashani, Erik Vassella
Cancers (2022) Vol. 14, Iss. 21, pp. 5227-5227
Open Access | Times Cited: 9
Elham Kashani, Erik Vassella
Cancers (2022) Vol. 14, Iss. 21, pp. 5227-5227
Open Access | Times Cited: 9
Glioblastoma Biology, Genetics and Possible Therapies
Javier S. Castresana, Bárbara Meléndez
Cells (2023) Vol. 12, Iss. 16, pp. 2063-2063
Open Access | Times Cited: 4
Javier S. Castresana, Bárbara Meléndez
Cells (2023) Vol. 12, Iss. 16, pp. 2063-2063
Open Access | Times Cited: 4
Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes
Bakiye Göker Bağca, Neslihan Pınar Özateş, Çığır Biray Avci
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 7
Bakiye Göker Bağca, Neslihan Pınar Özateş, Çığır Biray Avci
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 7
Computational modeling and synthesis of pyridine variants of benzoyl-phenoxy-acetamide with high glioblastoma cytotoxicity and brain tumor penetration
Charles H. Ingraham, Joanna Stalińska, Sean C. Carson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Charles H. Ingraham, Joanna Stalińska, Sean C. Carson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Drug resistance in glioblastoma: from chemo- to immunotherapy
Sachin Sharma, Oksana Chepurna, Tao Sun
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 688-708
Open Access | Times Cited: 2
Sachin Sharma, Oksana Chepurna, Tao Sun
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 688-708
Open Access | Times Cited: 2
Unveiling Gene Interactions in Alzheimer’s Disease by Integrating Genetic and Epigenetic Data with a Network-Based Approach
Keith L. Sanders, Astrid M. Manuel, Andi Liu, et al.
Epigenomes (2024) Vol. 8, Iss. 2, pp. 14-14
Open Access
Keith L. Sanders, Astrid M. Manuel, Andi Liu, et al.
Epigenomes (2024) Vol. 8, Iss. 2, pp. 14-14
Open Access
Computational modeling and synthesis of Pyridine variants of Benzoyl-Phenoxy-Acetamide with high glioblastoma cytotoxicity and brain tumor penetration
Charles H. Ingraham, Joanna Stalińska, Sean C. Carson, et al.
Research Square (Research Square) (2023)
Open Access
Charles H. Ingraham, Joanna Stalińska, Sean C. Carson, et al.
Research Square (Research Square) (2023)
Open Access
Advancements in stem cell-based therapeutics in phospholipase A2-dependent colorectal cancer
Diptimayee Das, C. Cynthia, Surajit Pathak, et al.
Elsevier eBooks (2023), pp. 63-85
Closed Access
Diptimayee Das, C. Cynthia, Surajit Pathak, et al.
Elsevier eBooks (2023), pp. 63-85
Closed Access
Modulation von Stammzellcharakteristika in Gliom-initiierenden Zellen durch GANT61 oder Arsentrioxid und (-)-Gossypol
Andrej Wehle
(2023)
Open Access
Andrej Wehle
(2023)
Open Access
Exploring VEGF-Linked Pathways: Investigating Multiple miRNAs for Their Therapeutic Potential in Angiogenesis Targets and as Biomarkers in Recurrent Glioblastoma Multiforme.
Morteza Hadizadeh, Ramin Soltani, Taimour Langaee, et al.
PubMed (2022) Vol. 11, Iss. 4, pp. 306-319
Closed Access
Morteza Hadizadeh, Ramin Soltani, Taimour Langaee, et al.
PubMed (2022) Vol. 11, Iss. 4, pp. 306-319
Closed Access